Lertsburapa Kirkeith, Ahlberg Alan W, Bateman Timothy M, Katten Deborah, Volker Lyndy, Cullom S James, Heller Gary V
Nuclear Cardiology Laboratory, Henry Low Heart Center, Division of Cardiology, Hartford Hospital, Hartford, CT 06102, USA.
J Nucl Cardiol. 2008 Nov-Dec;15(6):745-53. doi: 10.1007/BF03007355. Epub 2008 Sep 12.
Whether left ventricular ejection fraction (EF) obtained by gated rubidium 82 positron emission tomography (PET) myocardial imaging can identify patients at risk for future cardiac events is unclear.
Consecutive patients with known or suspected coronary artery disease who underwent dipyridamole stress gated Rb-82 PET imaging were evaluated. Scoring of perfusion was accomplished by use of a 17-segment model. EF was automatically generated. Patients were stratified based on summed stress scores (SSSs) (0-3, 4-8, or >8) and stress EF (>50%, 40%-49%, or <40%). All-cause mortality was determined by use of the Social Security Death Index. Of 1,441 patients, 132 (9.2%) died during mean follow-up of 2.7 +/- 0.8 years. Annualized mortality rates across SSS groups were 2.4% for SSS of 0 to 3, 4.1% for SSS of 4 to 8, and 6.9% for SSS greater than 8 (P < .001). Similarly, annualized mortality rates were 2.4%, 6.2%, and 9.2% for the group with EF greater than 50%, group with EF of 40% to 49%, and group with EF lower than 40%, respectively (P < .001). On multivariate analysis, the addition of EF to clinical and perfusion variables significantly increased the global chi(2) (73.3 to 107.7, P < .001). Integration of EF with SSS significantly enhanced risk stratification.
EF assessed by stress gated Rb-82 PET imaging provides independent and incremental prognostic information and, hence, should be routinely incorporated in risk assessment.
通过门控铷82正电子发射断层扫描(PET)心肌成像获得的左心室射血分数(EF)是否能识别未来发生心脏事件风险的患者尚不清楚。
对连续接受双嘧达莫负荷门控Rb - 82 PET成像的已知或疑似冠心病患者进行评估。灌注评分采用17节段模型完成。EF自动生成。患者根据负荷总分(SSS)(0 - 3、4 - 8或>8)和负荷EF(>50%、40% - 49%或<40%)进行分层。全因死亡率通过社会保障死亡指数确定。在1441例患者中,132例(9.2%)在平均2.7±0.8年的随访期间死亡。SSS组年化死亡率在SSS为0至3时为2.4%,SSS为4至8时为4.1%,SSS大于8时为6.9%(P < 0.001)。同样,EF大于50%组、EF为40%至49%组和EF低于40%组的年化死亡率分别为2.4%、6.2%和9.2%(P < 0.001)。多变量分析显示,将EF加入临床和灌注变量后显著增加了整体卡方值(从73.3增至107.7,P < 0.001)。EF与SSS整合显著增强了风险分层。
通过负荷门控Rb - 82 PET成像评估的EF提供独立且增量的预后信息,因此应常规纳入风险评估。